We recently compiled a list of the Jim Cramer’s Lightning Round: 7 Stocks Under the Spotlight. In this article, we are going ...

'Mad Money' host Jim Cramer weighs in on stock including: Anavex Life Sciences, Sarepta Therapeutics, Viking Therapeutics, ...

Jim Cramer in a latest program on CNBC commented on the bearish start of 2025 and said being a bear in the market is “easy” ...

Jim Cramer, host of Mad Money, recently shared his thoughts following his interview with President-elect Donald Trump on the floor of the New York Stock Exchange. One of the key takeaways for ...

CNBC’s Jim Cramer examined Wednesday’s market rally and stressed that it’s important to stay focused on corporate earnings ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

CNBC's Jim Cramer listed ten stocks he thinks will do well in December. Cramer said winners from November usually continue to perform during the last month of the year. Companies on the list ...

CNBC’s Jim Cramer on Wednesday told investors to be wary of market froth, especially volatile stocks related to quantum ...

CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and ...

CNBC's Jim Cramer examined Monday's market action, saying the tech-heavy Nasdaq failed to rally largely due to a unique ...

Jim Cramer urged investors to consider NVIDIA Corp.'s recent stock decline as a buying opportunity, despite the company's ...

CNBC’s Jim Cramer on Friday told investors why he thinks it’s a good time to buy sports betting platform DraftKings, whose ...